IL5 and asthma: Patients in the top quartile of the three cytokines that reflect current biological targets that are currently in clinic, that is, IL‐5, TSLP, IL‐4/13 (Supporting Information S1: Table S2) demonstrate 46.6% of the asthma patients were high for all three targets (Figure 1J).